Outcomes of pancreatic cancer with liver oligometastasis
暂无分享,去创建一个
N. Sasahira | A. Saiura | Y. Inoue | A. Kasuga | Takashi Sasaki | Tsuyoshi Takeda | M. Matsuyama | M. Ozaka | Takeshi Okamoto | Y. Takahashi
[1] F. Sonohara,et al. A Possible Definition of Oligometastasis in Pancreatic Cancer and Associated Survival Outcomes , 2021, Anticancer Research.
[2] J. Vermorken,et al. Oligometastatic Cancer: Key Concepts and Research Opportunities for 2021 and Beyond , 2021, Cancers.
[3] M. Meijerink,et al. Locoregional Treatment of Metastatic Pancreatic Cancer Utilizing Resection, Ablation and Embolization: A Systematic Review , 2021, Cancers.
[4] N. Sasahira,et al. Improved prognosis of pancreatic cancer patients with peritoneal metastasis. , 2021, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[5] S. K. Sherman,et al. Surgical Management of Neuroendocrine Tumor Liver Metastases. , 2021, Surgical oncology clinics of North America.
[6] T. Sato,et al. Staging laparoscopy for pancreatic cancer using intraoperative ultrasonography and fluorescence imaging: the SLING trial. , 2020, The British journal of surgery.
[7] Ricky A. Sharma,et al. The multidisciplinary management of oligometastases from colorectal cancer: a narrative review. , 2020, Annals of palliative medicine.
[8] A. Quaas,et al. Proposal for a definition of "Oligometastatic disease in pancreatic cancer" , 2019, BMC Cancer.
[9] A. Saiura,et al. Radiologically occult metastatic pancreatic cancer: how can we avoid unbeneficial resection? , 2019, Langenbeck's Archives of Surgery.
[10] M. Büchler,et al. CT response of primary tumor and CA19-9 predict resectability of metastasized pancreatic cancer after FOLFIRINOX. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[11] M. Del Chiaro,et al. Surgical treatment of metastatic pancreatic ductal adenocarcinoma: A review of current literature. , 2019, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[12] C. Braconi,et al. Oligometastatic gastric cancer: An emerging clinical entity with distinct therapeutic implications. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[13] M. Wallace,et al. Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma Treated with Combined Modality Treatment Including Surgical Resection: A Pilot Study , 2018, Journal of pancreatic cancer.
[14] D. Kwapisz. Oligometastatic breast cancer , 2018, Breast Cancer.
[15] Yongping Zhou,et al. Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: A meta-analysis containing 8252 patients. , 2018, Clinica chimica acta; international journal of clinical chemistry.
[16] J. Windsor,et al. International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. , 2017, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[17] K. Takaori. "International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017": Will this pull us up out of the quagmire of confusing definitions and criteria? , 2018, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[18] S. Popat,et al. Ablative Therapy for Oligometastatic Non–Small Cell Lung Cancer , 2017, Clinical lung cancer.
[19] Kun Wang,et al. Radiofrequency ablation for hepatic oligometastatic pancreatic cancer: An analysis of safety and efficacy. , 2017, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[20] C. Bassi,et al. Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? , 2017, Annals of Surgical Oncology.
[21] K. Pienta,et al. Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations , 2017, Nature Reviews Urology.
[22] M. Reni,et al. Is there a role for surgical resection in patients with pancreatic cancer with liver metastases responding to chemotherapy? , 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[23] elliot k fishman,et al. Primary Tumor Resection Following Favorable Response to Systemic Chemotherapy in Stage IV Pancreatic Adenocarcinoma with Synchronous Metastases: a Bi-institutional Analysis , 2016, Journal of Gastrointestinal Surgery.
[24] H. Imaoka,et al. Evaluation of Modified Glasgow Prognostic Score for Pancreatic Cancer: A Retrospective Cohort Study , 2016, Pancreas.
[25] Y. Kanda,et al. Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.
[26] M. Makuuchi,et al. Scenario 1 : Complication After a Surgical Procedure Not Caused by a Surgeon , 2022 .
[27] F. Ames,et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. , 1992, Archives of surgery.